Resources

Our publisher, Steve Freed, sat down with Dr. Steven Edelman at the ADA Scientific Sessions in San Diego, and asked, “When should we add the GLP-1 drugs in the progression of diabetes?” and “How comfortable are you with the safety of the GLP-1 drugs?” … Steve Freed:  Thanks for taking …

When making a choice amongst GLP-1 Agonists, the number of injections per day and when peak concentrations are reached are both important in selecting therapy. There was almost unanimous consensus that Exenatide is administered twice daily while Liraglutide is given only one time a day. It was interesting to note …

This week, after our publisher Steve Freed was able to connect up with Dr. Vinik again, we bring you more insight on the latest in GLP-1 therapy.  I asked Dr. Vinik , “Who is the ideal type 2 patient for GLP-1 treatment?” and “Can GLP-1 drugs prevent apoptosis and regenerate …

Edited by Trisha Dunning AM, RN, MEd, PhD, CDE, FRCNA and Glenn Ward MBBS, BSc, DPhil (Oxon), FRACP, FRCPath Mrs. MJ was referred to a diabetes centre by her GP.  Mrs. MJ, a 60-year-old woman with type 2 diabetes since 2000, presents with…

From Part 5 of our series on diabetic eye disease: "Chronic hyperglycemia unleashes a progressive cascade of events: Endothelial pericyte loss; RGC death; Increased vascular permeability; Capillary; Release of vasoproliferative factors; and Neovascularization, fibrovascular vitreo-retinal adhesions, vitreous hemorrhage."….

Drugs Show Promise for Preserving Body’s Ability to Produce Insulin The progression of type 1 diabetes may be slowed in those newly diagnosed through the use of promising new medications currently under development, according to data presented by researchers at the American Diabetes Association’s 71st Scientific Sessions®. Researchers believe these …

  GlucaPen™ Glucagon without prior mixing   GlucaPen is an auto-injector pen containing glucagon which is substantially different from the currently marketed hypo-kits. The design integrates the glucagon powder and diluent into a dual chamber cartridge within the pen. The pen also has a pre-attached needle which is only activated …

Results will be included in the BYDUREON™ New Drug Application Resubmission in the Third Quarter of 2011….

Outpatient electronic prescribing systems don’t cut out the common mistakes made in manual systems, suggests published research in JAMIA.…

New research from scientists in Canada has revealed that taking aspirin every day could offer benefits for those managing their diabetes….